BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -8.87%261.84M | -9.75%281.41M | 6.63%350.77M | 19.92%275.7M | 52.91%287.32M | 33.65%311.8M | 31.16%328.94M | 7.17%229.9M | -22.47%187.9M | -10.04%233.3M |
Notes receivable and accounts receivable | -31.38%2.38M | -35.64%2.02M | 22.15%3.49M | 16.43%3.45M | 39.22%3.46M | -43.58%3.14M | 159.89%2.86M | 156.26%2.96M | 264.57%2.49M | 204.27%5.56M |
-Accounts receivable | -31.38%2.38M | -35.64%2.02M | 22.15%3.49M | 16.43%3.45M | 39.22%3.46M | -43.58%3.14M | 159.89%2.86M | 156.26%2.96M | 264.57%2.49M | 204.27%5.56M |
Other receivables (including interest and dividends) | -10.26%949.48K | 80.72%1.12M | -11.49%3.32M | -27.52%3.92M | -16.70%1.06M | 33.64%619.1K | 176.43%3.75M | 330.22%5.41M | 142.12%1.27M | -1.16%463.25K |
-Other receivable | ---- | ---- | ---- | -27.52%3.92M | ---- | 33.64%619.1K | ---- | 330.22%5.41M | ---- | -1.16%463.25K |
Advance payment | 1.37%3.37M | 103.03%4.56M | -17.26%3.45M | 90.19%3.99M | 194.48%3.32M | 117.49%2.25M | 199.29%4.17M | 58.43%2.1M | -3.72%1.13M | -17.09%1.03M |
Inventories | 128.44%2.7M | 127.53%2.68M | 39.13%1.75M | 40.58%1.74M | 11.16%1.18M | 8.62%1.18M | 14.22%1.26M | 28.17%1.24M | 3.91%1.06M | 7.12%1.09M |
Other current assets | 381.92%21.12M | 355.51%19.92M | 631.36%10.67M | 1,037.46%2.52M | 193.89%4.38M | 156.76%4.37M | 387.34%1.46M | 21,808.18%221.7K | -60.35%1.49M | -55.67%1.7M |
Total current assets | -2.78%292.35M | -3.60%311.71M | 9.05%373.44M | 20.47%291.31M | 53.95%300.72M | 32.98%323.35M | 33.74%342.43M | 10.31%241.82M | -21.71%195.34M | -9.19%243.15M |
Non Current assets | ||||||||||
Investment real estate | -3.68%3.87M | -3.65%3.91M | -59.96%3.95M | -59.97%3.98M | -59.98%4.02M | -59.99%4.06M | -3.70%9.85M | -3.66%9.95M | -3.63%10.04M | -3.60%10.14M |
Long-term equity investment | 4.49%96.18M | 4.55%96.61M | 5.54%95.54M | 5.04%92.01M | 7.30%92.04M | 7.72%92.41M | 4.53%90.53M | 1.40%87.59M | -0.68%85.78M | -0.68%85.78M |
Fixed assets | ---- | ---- | ---- | 17.49%238.55M | ---- | 7.89%226.36M | ---- | -7.82%203.05M | ---- | 27.80%209.82M |
Constru in process | ---- | ---- | ---- | --14.95M | ---- | --39.65K | ---- | ---- | ---- | ---- |
Intangible assets | -5.23%115.28M | -5.24%116.97M | -2.27%118.09M | -2.16%119.87M | -2.04%121.65M | -1.93%123.43M | -5.26%120.83M | -5.19%122.51M | -5.15%124.19M | -5.12%125.86M |
Long deferred expense | 889,385.73%104.75M | 514,884.21%106.13M | ---- | --2.94K | --11.78K | --20.61K | --35.33K | ---- | ---- | ---- |
Deferred tax assets | -7.07%864.14K | -7.08%863.97K | 153.27%1.07M | 193.59%1.02M | 126.51%929.83K | 2.19%929.83K | -13.36%420.56K | -28.02%347.86K | -14.78%410.51K | 88.91%909.95K |
Usufruct assets | 863.05%75.07M | 832.85%76.62M | -9.95%7.82M | -9.83%8.29M | 502.20%7.8M | 523.95%8.21M | 545.33%8.69M | 571.80%9.19M | -98.12%1.29M | -98.09%1.32M |
Other non current assets | -50.29%6.37M | 173.95%9.44M | 154.18%16.51M | -39.53%14.07M | 107.54%12.82M | -44.04%3.45M | --6.5M | --23.27M | --6.18M | --6.16M |
Total non current assets | 64.38%762.6M | 69.65%778.53M | 28.64%589.88M | 8.08%492.74M | 7.31%463.94M | 4.30%458.91M | 3.18%458.56M | 1.06%455.9M | -5.72%432.35M | -5.62%439.98M |
Total assets | 37.96%1.05B | 39.37%1.09B | 20.27%963.32M | 12.37%784.05M | 21.82%764.66M | 14.51%782.26M | 14.35%800.99M | 4.09%697.72M | -11.35%627.69M | -6.92%683.13M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Notes payable and accounts payable | 1,086.11%59.83M | 1,001.30%74.38M | -29.54%4.85M | -16.16%7.69M | -8.91%5.04M | -27.68%6.75M | -11.00%6.88M | -0.88%9.17M | -29.40%5.54M | 13.24%9.34M |
-Accounts payable | 1,086.11%59.83M | 1,001.30%74.38M | -29.54%4.85M | -16.16%7.69M | -8.91%5.04M | -27.68%6.75M | -11.00%6.88M | -0.88%9.17M | -29.40%5.54M | 13.24%9.34M |
Contract liabilities | 8.49%1.32M | 12.06%1.05M | 167.26%905.62K | 221.66%911.51K | 389.87%1.22M | 217.38%935.57K | 86.15%338.85K | 125.98%283.38K | 1,214.99%248.11K | 73.12%294.78K |
Advance receipts | -4.03%1.68M | 12.41%1.72M | 171.77%3.21M | -2.17%1.09M | 2,840.75%1.75M | 2,681.24%1.53M | 379.62%1.18M | 115.35%1.11M | -92.36%59.66K | -94.06%54.96K |
Salaries payable | -1.13%13.67M | -31.83%11.53M | 40.11%1.83M | 1,368.15%13.69M | 1,188.18%13.82M | 1,394.71%16.91M | -9.29%1.31M | -21.16%932.77K | -30.09%1.07M | -79.96%1.13M |
Taxs payable | 29.92%894.36K | -28.14%685.81K | -7.02%18.34M | -28.63%6.08M | 35.28%688.41K | 1,299.49%954.43K | 546.50%19.72M | 791.57%8.52M | 5.65%508.89K | -54.01%68.2K |
Other payable (including interest and dividends) | 160.30%9.78M | 167.04%10.99M | 19.39%5.41M | 5.29%5.46M | 7.46%3.76M | -14.51%4.11M | 12.89%4.53M | 62.52%5.18M | 3.68%3.49M | 43.04%4.81M |
-Interest payable | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
-Dividend payable | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | ---- | ---- | ---- | 5.29%5.46M | ---- | -14.51%4.11M | ---- | 62.52%5.18M | ---- | 43.04%4.81M |
Hold and for sell liabilities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
Non current liabilities due within one year | 942.10%17.21M | 1,192.08%21.34M | 1,102.40%2.15M | 1,102.40%2.15M | 822.98%1.65M | -95.56%1.65M | 383.20%178.94K | 30.37%178.94K | -97.46%178.94K | 267.50%37.23M |
Other current liabilities | 16.54%26.08K | 41.55%10.97K | 20.69%6.34K | 80.04%9.46K | 306.34%22.38K | 26.08%7.75K | 117.80%5.25K | 138.02%5.25K | 71.56%5.51K | 91.42%6.15K |
Total current liabilities | 273.48%104.4M | 270.36%121.71M | 7.47%36.7M | 46.09%37.08M | 151.69%27.95M | -37.93%32.86M | 104.40%34.15M | 65.26%25.38M | -47.27%11.11M | 84.87%52.94M |
Current liabilities | ||||||||||
Long term loan | --118.09M | --106.98M | --99.38M | --4.76M | ---- | ---- | ---- | ---- | ---- | ---- |
Deferred tax liabilities | -43.24%87.48K | -43.24%87.48K | -1.52%66.4K | -11.64%66.4K | 84.53%154.13K | 70.14%154.13K | -39.44%67.42K | -32.50%75.15K | -34.16%83.53K | -28.58%90.59K |
Long term deferred income | -11.60%12.01M | -11.28%12.4M | -10.96%12.8M | -10.68%13.18M | -10.39%13.59M | -10.14%13.97M | -10.07%14.38M | -10.53%14.76M | -10.11%15.17M | -10.04%15.55M |
Lease liabilities | 1,144.66%74.69M | 1,102.79%72.17M | -8.49%6.92M | -8.75%6.89M | 360.71%6M | 364.76%6M | 420.33%7.56M | 463.09%7.55M | -8.87%1.3M | -5.88%1.29M |
Total non current liabilities | 937.65%204.87M | 852.14%191.64M | 441.47%119.17M | 11.23%24.9M | 19.29%19.74M | 18.88%20.13M | -59.66%22.01M | -59.26%22.39M | -75.81%16.55M | -75.41%16.93M |
Total liabilities | 548.41%309.27M | 491.34%313.34M | 177.57%155.87M | 29.75%61.98M | 72.46%47.7M | -24.16%52.99M | -21.19%56.16M | -32.06%47.77M | -69.09%27.66M | -28.33%69.87M |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%155M | 0.00%155M | 0.00%155M | 0.00%155M | 0.00%155M | 0.00%155M | 0.00%155M | 0.00%155M | 0.00%155M | 0.00%155M |
Other equity instruments | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Equity of prefer stock | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Equity of Perpetual debt | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Capital reserve funds | 0.00%296.84M | 0.00%296.84M | 0.00%296.84M | 0.00%296.84M | 0.00%296.84M | 0.00%296.84M | 0.00%296.84M | 0.00%296.84M | 0.00%296.84M | 0.00%296.84M |
Surplus reserve funds | 26.97%56.92M | 26.97%56.92M | 26.21%44.83M | 26.21%44.83M | 26.21%44.83M | 26.21%44.83M | 0.00%35.52M | 0.00%35.52M | 0.00%35.52M | 0.00%35.52M |
Retained profit | 4.93%218.9M | 12.66%248.52M | 16.21%289.41M | 31.24%203.46M | 87.39%208.61M | 77.44%220.59M | 75.43%249.03M | 37.09%155.04M | -15.38%111.33M | -16.63%124.32M |
Ordinary risk reserve funds | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Specific reserves | 15.49%313.33K | 15.49%313.33K | 36.63%264.3K | 36.63%264.3K | 25.62%271.3K | 25.62%271.3K | 25.38%193.45K | 25.38%193.45K | 39.97%215.97K | 39.97%215.97K |
Shareholders equity without minority interests | 3.18%727.98M | 5.58%757.59M | 6.76%786.34M | 9.00%700.4M | 17.81%705.55M | 17.26%717.53M | 17.02%736.58M | 6.99%642.59M | -3.26%598.9M | -3.89%611.89M |
Minority interests | 55.17%17.7M | 64.45%19.31M | 155.56%21.11M | 194.24%21.67M | 910.27%11.41M | 761.34%11.74M | 3,304.11%8.26M | 1,384.98%7.36M | 335.12%1.13M | 699.79%1.36M |
Total shareholder equity | 4.01%745.68M | 6.53%776.89M | 8.41%807.45M | 11.10%722.07M | 19.49%716.96M | 18.92%729.27M | 18.38%744.84M | 8.32%649.95M | -3.00%600.03M | -3.64%613.26M |
Total liabilityies and equity | 37.96%1.05B | 39.37%1.09B | 20.27%963.32M | 12.37%784.05M | 21.82%764.66M | 14.51%782.26M | 14.35%800.99M | 4.09%697.72M | -11.35%627.69M | -6.92%683.13M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.